The Heat Map shows these symbols by color. Each symbol can be clicked to scroll to the symbol details.
Below is a clickable Heat Map of the 1 symbols on this page. The percent change is based on Wednesday's prices. Each symbol is a hyperlink or shortcut to more information.CLVS 19.74%
Market Cap 320 Million
Clovis Oncology Inc is a biopharmaceutical company. It is focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, the EU, and additional international markets. The firm target its development programs for the treatment of specific subsets of cancer populations. Its product candidates include Rucaparib and Lucitanib. Rucaparib is an oral small molecule inhibitor of poly ADP-ribose polymerase, is marketed in the United States for two indications specific to the recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer whereas Lucitanib includes Rucaparib Combo and Nivolumab Combo.
EPS -1.72 P/E Ratio --
Previous Thu, Aug 1, 2019
Latest Tue, Oct 29, 2019 (15 days ago) Price +65.82%
Pay Date --
|Symbol||Price||Day Δ||YTD Δ|
How can we make Symbol Surfing better?
©2019 Symbol Surfing All Rights Reserved.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.